PD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Management of Young and Ageing Women with Afibrinogenemia and Hypofibrinogenemia | Hämostaseologie |  | 2025 | 2 | 1 | ||
| Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database | Blood advances | | 2024 | 98 | 39 | ||
| Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen | Journal of thrombosis and haemostasis |  | 2024 | 71 | 0 | ||
| Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | | 2024 | 47 | 0 | ||
| Challenges in the diagnosis and management of patients with rare coagulation disorders in Lebanon and consequences of a social and economic crisis | Haemophilia | | 2024 | 34 | 0 | ||
| High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia | Haemophilia | | 2023 | 47 | 0 | ||
| Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group | Haemophilia | | 2023 | 81 | 0 | ||
| One Hundred Years of Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | 2022 | 291 | 0 | ||
| New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia | Thrombosis and haemostasis | | 2022 | 133 | 0 | ||
| How I treat dysfibrinogenemia | Blood | | 2021 | 309 | 501 | ||
| Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia | Blood | | 2021 | 268 | 136 | ||
| Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls | Blood Coagulation and Fibrinolysis | | 2021 | 214 | 0 | ||
| Molecular characterization of two hypofibrinogenemic patients associated with a novel FGG IVS6+23T>A substitution and a previously reported FGB IVS6-10_16delTTTG deletion | Haemophilia |  | 2020 | 320 | 0 | ||
| Unravelling the knowledge, beliefs, behaviours and concerns of Persons with Haemophilia and their carriers in Senegal | Haemophilia | | 2020 | 123 | 0 | ||
| Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management | Blood Reviews | | 2020 | 244 | 259 | ||
| Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future | Haemophilia | | 2019 | 288 | 0 | ||
| Impaired factor XIII activation in patients with congenital afibrinogenemia | Haematologica | | 2019 | 329 | 104 | ||
| The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia | Haemophilia | | 2019 | 358 | 0 | ||
| Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus | Rheumatology | | 2018 | 373 | 1 | ||
| Mutational epidemiology of congenital fibrinogen disorders | Thrombosis and Haemostasis | | 2018 | 561 | 605 | ||
| Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | | 2018 | 418 | 26 | ||
| Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization | Haemophilia | | 2017 | 415 | 1 | ||
| A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system | Journal of thrombosis and haemostasis | | 2017 | 532 | 3 | ||
| Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation | Journal of thrombosis and haemostasis | | 2017 | 579 | 198 | ||
| Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues | Haematologica | | 2017 | 503 | 199 | ||
| Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia | Haemophilia | | 2017 | 529 | 4 | ||
| Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | 2016 | 564 | 0 | ||
| Pregnancy | Trauma Induced Coagulopathy | | 2016 | 415 | 2 | ||
| Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe | Haemophilia | | 2016 | 383 | 0 | ||
| Clinical Features and Management of Congenital Fibrinogen Deficiencies | Seminars in thrombosis and hemostasis | | 2016 | 578 | 5 | ||
| Can the phenotype of inherited fibrinogen disorders be predicted? | Haemophilia | | 2016 | 620 | 2 | ||
| Preoperative hemostatic assessment: a new and simple bleeding questionnaire | Canadian journal of anaesthesia | | 2016 | 486 | 0 | ||
| F-actin dampens NLRP3 inflammasome activity via Flightless-I and LRRFIP2 | Scientific reports | | 2016 | 615 | 271 | ||
| Factor concentrates for rare congenital coagulation disorders: where are we now? | Expert opinion on orphan drugs | | 2016 | 435 | 0 | ||
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | | 2016 | 517 | 0 | ||
| Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management | Nonmalignant Hematology Expert Clinical Review : Questions and Answers | | 2016 | 485 | 0 | ||
| Natural history of patients with congenital dysfibrinogenemia | Blood | | 2015 | 709 | 4 | ||
| Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis | Haemophilia | | 2015 | 501 | 0 | ||
| Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial | Journal of thrombosis and haemostasis | | 2015 | 469 | 0 | ||
| Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management | Journal of thrombosis and haemostasis | | 2015 | 683 | 428 | ||
| Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature | Haemophilia | | 2015 | 554 | 5 | ||
| NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes | Journal of thrombosis and haemostasis | | 2014 | 511 | 0 | ||
| Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies | Journal of thrombosis and haemostasis | | 2014 | 595 | 0 | ||
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | | 2014 | 635 | 3 | ||
| Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood | Thrombosis research | | 2014 | 597 | 2 | ||
| Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies | Journal of thrombosis and haemostasis | | 2014 | 612 | 5 | ||
| FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations | Thrombosis research | | 2014 | 666 | 9 | ||
| Predicting deep venous thrombosis in pregnancy : external validation of the LEFT clinical prediction rule | Haematologica | | 2013 | 39 | 56 | ||
| Acquired factor XIII deficiency: a therapeutic challenge | Thrombosis and haemostasis | | 2013 | 627 | 0 | ||
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | | 2013 | 398 | 0 | ||
| Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery | Blood coagulation & fibrinolysis | | 2013 | 490 | 0 | ||
| Receptors involved in cell activation by antiphospholipid antibodies | Thrombosis research | | 2013 | 619 | 550 | ||
| Could Factor XIII be a solution for the management of surgical bleeding? | Management and Severe Bleeding | | 2013 | 362 | 0 | ||
| TLR2 ligands induce NF-κB activation from endosomal compartments of human monocytes | PloS one | | 2013 | 527 | 352 | ||
| Congenital fibrinogen disorders: an update | Seminars in thrombosis and hemostasis | | 2013 | 722 | 0 | ||
| Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand? | Polskie Archiwum Medycyny Wewnętrznej | | 2013 | 575 | 2 | ||
| Obstetrical Antiphospholipid Syndrome: From the Pathogenesis to the Clinical and Therapeutic Implications | Clinical & developmental immunology | | 2013 | 646 | 2 | ||
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | | 2012 | 717 | 29 | ||
| Thrombophilie : quel bilan en 2012? | La Revue de médecine interne | | 2012 | 483 | 0 | ||
| Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex | Journal of internal medicine | | 2012 | 733 | 3 | ||
| Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency | Blood coagulation & fibrinolysis | | 2012 | 561 | 0 | ||
| Inflammatory and prothrombotic states in obese children of European descent | Obesity | | 2012 | 527 | 0 | ||
| Mutation of the translation initiation codon in FGA causes congenital afibrinogenemia | Blood coagulation & fibrinolysis | | 2012 | 590 | 0 | ||
| Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients | Thrombosis and haemostasis | | 2011 | 631 | 0 | ||
| Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies | Blood | | 2011 | 572 | 0 | ||
| A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family | Blood coagulation & fibrinolysis | | 2011 | 648 | 1 | ||
| Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients | Blood coagulation & fibrinolysis | | 2010 | 614 | 0 | ||
| Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency | Thrombosis and haemostasis | | 2010 | 596 | 0 | ||
| Fibrinogen and the risk of thrombosis | Seminars in thrombosis and hemostasis | | 2010 | 577 | 2 | ||
| Stenting carotidien: place de l'evidence-based medicine! | Revue médicale suisse | 2010 | 489 | 0 | |||
| Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome | Journal of thrombosis and haemostasis | | 2010 | 583 | 0 | ||
| Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A' | Thrombosis and haemostasis | | 2010 | 660 | 281 | ||
| Hémostase. Le point sur les nouveaux antithrombotiques | Revue médicale suisse | 2010 | 523 | 0 | |||
| The role of prophylaxis in bleeding disorders | Haemophilia | | 2010 | 493 | 0 | ||
| Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? | Revue médicale suisse | 2010 | 505 | 0 | |||
| Introduction de l'acénocoumarol à l'aide d'un algorithme de prescription | Revue médicale suisse | 2010 | 585 | 0 | |||
| Syndrome des anticorps antiphospholipides: beaucoup de nouveautés | Revue médicale suisse | 2010 | 519 | 0 | |||
| Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery | Thrombosis and haemostasis | | 2010 | 624 | 0 | ||
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | | 2010 | 578 | 0 | ||
| The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study | Journal of thrombosis and haemostasis | | 2009 | 540 | 0 | ||
| European curriculum for thrombosis and haemostasis | Haemophilia | | 2009 | 468 | 0 | ||
| Diagnosis of mild bleeding disorders | Schweizerische medizinische Wochenschrift | | 2009 | 606 | 1,062 | ||
| Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function | Thrombosis and haemostasis | | 2009 | 625 | 1 | ||
| Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations | Thrombosis and haemostasis | 2009 | 514 | 0 | |||
| Evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism | Journal of thrombosis and haemostasis | | 2009 | 524 | 0 | ||
| Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations | Haemophilia | 2009 | 478 | 0 | |||
| Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique | La Revue de médecine interne | | 2009 | 541 | 0 | ||
| Anticoagulants in portal vein thrombosis: don't be so shy! | Blood | | 2009 | 484 | 0 | ||
| Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation | Blood coagulation & fibrinolysis | | 2009 | 535 | 0 | ||
| A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream | Blood coagulation & fibrinolysis | | 2009 | 613 | 4 | ||
| Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? | Journal of thrombosis and haemostasis | | 2009 | 502 | 0 | ||
| Congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | 2009 | 610 | 0 | |||
| Assessing aspirin responsiveness using the Verify Now Aspirin assay | Thrombosis research | | 2008 | 622 | 0 | ||
| Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides | Molecular immunology | | 2008 | 628 | 0 | ||
| Treatment of congenital fibrinogen disorders | Expert opinion on biological therapy | 2008 | 535 | 0 | |||
| Chapter 12 Blood coagulation and fibrinolysis: mechanisms of thrombosis | Handbook of clinical neurology | | 2008 | 526 | 0 | ||
| Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency | Blood | | 2008 | 629 | 0 | ||
| A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism | Thrombosis and haemostasis | 2008 | 685 | 0 | |||
| Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream? | Seminars in thrombosis and hemostasis | 2008 | 583 | 0 | |||
| Invitation to a debate on the serological criteria that define the antiphospholipid syndrome | Journal of thrombosis and haemostasis | | 2008 | 559 | 0 | ||
| Molecular analysis of F8 in Lebanese haemophilia A patients: novel mutations and phenotype-genotype correlation | Haemophilia | | 2008 | 568 | 0 | ||
| A survey of adherence to haemophilia therapy in six European countries: results and recommendations | Haemophilia | | 2008 | 616 | 0 | ||
| Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | 2008 | 640 | 0 | ||
| Preventing and treating bleeding complications: new insights into therapeutic options | Thrombosis research | | 2008 | 511 | 0 | ||
| D-Dimer for venous thromboembolism diagnosis: 20 years later | Journal of thrombosis and haemostasis | | 2008 | 610 | 0 | ||
| Mécanismes d'activation cellulaire par les anticorps antiphospholipides | Hématologie | 2008 | 581 | 0 | |||
| Rare bleeding disorders | Haemophilia | | 2008 | 543 | 0 | ||
| Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome | Haematologica | | 2008 | 628 | 405 | ||
| Aspirin "resistance" and risk of cardiovascular morbidity | BMJ. British medical journal | | 2008 | 515 | 1 | ||
| A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis | Blood coagulation & fibrinolysis | | 2008 | 552 | 0 | ||
| Aspirin response variability assessed with the PFA-100 device | Thrombosis and haemostasis | 2008 | 590 | 0 | |||
| Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques | Thrombosis and haemostasis | | 2007 | 581 | 186 | ||
| Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique | Revue médicale suisse | 2007 | 393 | 0 | |||
| Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations | Human mutation | | 2007 | 592 | 1 | ||
| Extensive thromboembolic event as initial presentation of monoclonal gammopathy of undetermined significance | Thrombosis and haemostasis | | 2006 | 33 | 0 | ||
| Combined factor V - factor VIII deficiency (F5F8D): compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient | Thrombosis and haemostasis | | 2006 | 639 | 0 | ||
| Homozygosity for a Thr575Met missense mutation in the catalytic domain associated with factor XI deficiency | Haematologica | | 2005 | 467 | 0 | ||
| Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation | Journal of thrombosis and haemostasis | | 2005 | 462 | 0 | ||
| Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion | Journal of medical genetics | | 2005 | 485 | 1 | ||
| Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies | Thrombosis and haemostasis | | 2005 | 687 | 345 | ||
| Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia | Human molecular genetics | | 2005 | 648 | 4 | ||
| Severe factor XI deficiency in a Lebanese family: identification of a novel missense mutation (Trp501Cys) in the catalytic domain | Blood coagulation & fibrinolysis | | 2004 | 518 | 0 | ||
| Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells | Blood | | 2004 | 633 | 0 | ||
| Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cutoff Value in Outpatients With Suspected Pulmonary Embolism | Archives of internal medicine | | 2004 | 6 | 0 | ||
| Potential role of D‐dimer to rule in pulmonary embolism : a rebuttal | Journal of thrombosis and haemostasis | | 2004 | 44 | 33 | ||
| Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease | Journal of autoimmunity | | 2004 | 510 | 0 | ||
| Purpura fulminans in a child as a complication of chickenpox infection | Dermatology | | 2004 | 513 | 0 | ||
| Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion | Blood | | 2003 | 559 | 0 | ||
| Are patients with paroxysmal nocturnal hemoglobinuria at risk for heparin-induced thrombocytopenia ? | Journal of thrombosis and haemostasis | | 2003 | 63 | 85 | ||
| Rofecoxib interaction with oral anticoagulant acenocoumarol | European journal of clinical pharmacology | | 2003 | 466 | 220 | ||
| Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation | The European respiratory journal | | 2002 | 620 | 705 | ||
| Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes | Human genetics | | 2001 | 597 | 0 | ||
| Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G→T | Blood | | 2001 | 580 | 0 | ||
| Localization of beta2-glycoprotein 1 in late endosomes of human endothelial cells | Thrombosis and haemostasis | | 2001 | 78 | 0 | ||
| Should the D-dimer Cut-off Value Be Increased in Elderly Patients Suspected of Pulmonary Embolism ? | Thrombosis and haemostasis | | 2001 | 11 | 0 | ||
| Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty | Blood coagulation & fibrinolysis | | 2000 | 483 | 0 | ||
| Interaction of Anti-Phospholipid Antibodies With Late Endosomes of Human Endothelial Cells | Arteriosclerosis, thrombosis, and vascular biology | | 2000 | 469 | 1 | ||
| Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia | Blood | | 2000 | 560 | 1 | ||
| Massive thromboembolism due to transcatheter ASD closure with ASDOS device | The Journal of invasive cardiology | | 1999 | 429 | 0 | ||
| Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors | Haemophilia | | 1999 | 569 | 0 | ||
| Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty | Blood coagulation & fibrinolysis | | 1998 | 533 | 0 | ||
| Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up | Age and ageing | | 1997 | 558 | 125 | ||
| Factor VIII gene inversions in severe hemophilia A: results of an international consortium study | Blood | | 1995 | 560 | 3 | ||
| Molecular etiology of factor VIII deficiency in hemophilia A | Advances in experimental medicine and biology | 1995 | 545 | 0 | |||
| Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems | The international journal of artificial organs | 1990 | 643 | 0 |
